This report addresses particular accounting issues the pharmaceuticals and life sciences sector faces when using the International Financial Reporting Standards (IFRS). The aim is to highlight the industry-specific factors which need to be considered, and to provide an opinion on the most pertinent accounting solutions for common commercial transactions under IFRS. Each solution is based on a specified set of circumstances. They cover general situations and provide a framework for determining the appropriate accounting answer but individual fact patterns may give rise to a different answer. Examples cover various practices in the following areas:
Global Pharmaceutical and Life Sciences Assurance Leader, PwC Switzerland
Tel: +41 79 5429018